Banner

Hereditary Cancer Testing Market Report 2023 – By Test Type (Multi Panel Test, Single-site Genetic Test), By Indication (Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications), By End user (Hospital, Clinics, Diagnostic Centers) – Market Size, Trends, And Market Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment.

The main types of tests for hereditary cancer are multi panel tests and single-site genetic tests. The multi-panel test refers to a hereditary cancer test that is used to detect many chemicals simultaneously. Panels come in a variety of types, from three-panel tests that look for three substances to five, seven, and 12-panel tests. The choice of conducting the required number of tests is up to a tester’s discretion. Hereditary cancer testing is conducted to detect breast cancer, ovarian cancer, colorectal cancer, and other indications that are used in hospitals, clinics, and diagnostic centers.

The hereditary cancer testing market research report is one of a series of new reports from The Business Research Company that provides hereditary cancer testing market statistics, including hereditary cancer testing industry global market size, regional shares, competitors with a hereditary cancer testing market share, detailed hereditary cancer testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary cancer testing industry. This hereditary cancer testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global hereditary cancer testing market size is expected to grow from $3.55 billion in 2022 to $3.95 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hereditary cancer testing market size is expected to grow to $5.82 billion in 2027 at a CAGR of 10.2%.

The increasing prevalence of hereditary cancer is expected to drive the hereditary cancer testing market. Mutations in specific genes passed down from parents to children cause hereditary cancer syndromes. Hereditary cancer testing can detect specific, heritable, disease-related gene mutations, allowing for a comprehensive cancer risk assessment for patients. For instance, in June 2022, according to an article published on BioMed Central about hereditary cancer in clinical practise, about 10% of pancreatic cancer cases have a genetic background. Furthermore, in May 2021, a Europe-based software company called SOPHiA Genetics, a data-driven medicine software company, stated in an article that hereditary factors account for approximately 10% of cancer cases, with an estimated 20% of cancer patients having a cancer family history. Therefore, the increasing prevalence of hereditary cancer drives the growth of the hereditary cancer testing market.

Technological innovation is a key trend gaining popularity in the hereditary cancer testing market. Key players in the market are focusing on technological innovations to sustain their market positions. For instance, in March 2022, Myriad Genetics, a US-based genetic testing and precision medicine company, launched genetic testing with a Polygenic Breast Cancer Risk Assessment Score for all ancestries. This MyRisk Hereditary Cancer test with RiskScore offers a personalized breast cancer risk assessment to all women who have never been diagnosed with breast cancer, regardless of ancestry.

In January 2020, Quest Diagnostics, a US-based clinical laboratory company, acquired Blueprint Genetics for an undisclosed amount. With this acquisition, Quest and Blueprint Genetics will improve patient care and pharmaceutical medication research and development by increasing access to practical insights into genetic and rare diseases. Blueprint Genetics is a US-based company offering complete genetic testing and genetic diagnostics to medical professionals.

Major players in the hereditary cancer testing market are Centogene NV, Ambry Genetics, Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics, Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health, CooperSurgica Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes, Counsyl, and ARUP Laboratories

North America was the largest region in the hereditary cancer testing market in 2022. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the hereditary cancer testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The hereditary cancer testing market includes revenues earned by entities by providing hereditary cancer testing for lung cancer, cervical cancer, prostate cancer, stomach/gastric cancer, melanoma, sarcoma, and uterine cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global hereditary cancer testing market is segmented -

1) By Test Type: Multi Panel Test, Single-site Genetic Test

2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

3) By End user: Hospital, Clinics, Diagnostic Centers

    Table Of Contents

    1. Executive Summary

    2. Hereditary Cancer Testing Market Characteristics

    3. Hereditary Cancer Testing Market Trends And Strategies

    4. Hereditary Cancer Testing Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Hereditary Cancer Testing Market

    4.2. Ukraine-Russia War Impact On Hereditary Cancer Testing Market

    4.3. Impact Of High Inflation On Hereditary Cancer Testing Market

    5. Hereditary Cancer Testing Market Size And Growth

    5.1. Global Hereditary Cancer Testing Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Hereditary Cancer Testing Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Hereditary Cancer Testing Market Segmentation

    6.1. Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Multi Panel Test

    Single-Site Genetic Test

    6.2. Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Breast Cancer

    Ovarian Cancer

    Colorectal Cancer

    Other Indications

    6.3. Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital

    Clinics

    Diagnostic Centers

    7. Hereditary Cancer Testing Market Regional And Country Analysis

    7.1. Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Hereditary Cancer Testing Market

    8.1. Asia-Pacific Hereditary Cancer Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Hereditary Cancer Testing Market

    9.1. China Hereditary Cancer Testing Market Overview

    9.2. China Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Hereditary Cancer Testing Market

    10.1. India Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Hereditary Cancer Testing Market

    11.1. Japan Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Hereditary Cancer Testing Market

    12.1. Australia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Hereditary Cancer Testing Market

    13.1. Indonesia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Hereditary Cancer Testing Market

    14.1. South Korea Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Hereditary Cancer Testing Market

    15.1. Western Europe Hereditary Cancer Testing Market Overview

    15.2. Western Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Hereditary Cancer Testing Market

    16.1. UK Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Hereditary Cancer Testing Market

    17.1. Germany Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Hereditary Cancer Testing Market

    18.4. France Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Hereditary Cancer Testing Market

    19.1. Eastern Europe Hereditary Cancer Testing Market Overview

    19.2. Eastern Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Hereditary Cancer Testing Market

    20.1. Russia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Hereditary Cancer Testing Market

    21.1. North America Hereditary Cancer Testing Market Overview

    21.2. North America Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Hereditary Cancer Testing Market

    22.1. USA Hereditary Cancer Testing Market Overview

    22.2. USA Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Hereditary Cancer Testing Market

    23.1. South America Hereditary Cancer Testing Market Overview

    23.2. South America Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Hereditary Cancer Testing Market

    24.1. Brazil Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Hereditary Cancer Testing Market

    25.1. Middle East Hereditary Cancer Testing Market Overview

    25.2. Middle East Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Hereditary Cancer Testing Market

    26.1. Africa Hereditary Cancer Testing Market Overview

    26.2. Africa Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Hereditary Cancer Testing Market Competitive Landscape And Company Profiles

    27.1. Hereditary Cancer Testing Market Competitive Landscape

    27.2. Hereditary Cancer Testing Market Company Profiles

    27.2.1. Centogene NV

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Ambry Genetics

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Myriad Genetics Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. NeoGenomics Laboratories Inc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Quest Diagnostics

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Hereditary Cancer Testing Market

    29. Hereditary Cancer Testing Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Centogene NV Financial Performance
  • Table 47: Ambry Genetics Financial Performance
  • Table 48: Myriad Genetics Inc Financial Performance
  • Table 49: NeoGenomics Laboratories Inc Financial Performance
  • Table 50: Quest Diagnostics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Centogene NV Financial Performance
  • Figure 47: Ambry Genetics Financial Performance
  • Figure 48: Myriad Genetics Inc Financial Performance
  • Figure 49: NeoGenomics Laboratories Inc Financial Performance
  • Figure 50: Quest Diagnostics Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report